MQS Management LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,109 shares of the conglomerate’s stock, valued at approximately $779,000. Danaher comprises about 0.5% of MQS Management LLC’s portfolio, making the stock its 24th largest position.
A number of other large investors have also modified their holdings of DHR. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter valued at about $25,000. Elevated Capital Advisors LLC bought a new position in Danaher in the 4th quarter worth about $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on DHR. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Argus cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Piper Sandler started coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. The Goldman Sachs Group decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Finally, Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.
Danaher Price Performance
NYSE DHR opened at $190.26 on Wednesday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The firm has a market capitalization of $134.66 billion, a PE ratio of 36.80, a P/E/G ratio of 2.46 and a beta of 0.81. The company’s 50 day simple moving average is $178.72 and its 200 day simple moving average is $201.03.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.88 earnings per share. As a group, equities research analysts forecast that Danaher Corporation will post 8.44 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
